Showing 281 - 300 results of 42,093 for search '(( 5 we decrease ) OR ( 50 ((ns decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 0.97s Refine Results
  1. 281
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286
  7. 287
  8. 288
  9. 289
  10. 290
  11. 291
  12. 292
  13. 293
  14. 294

    The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors by T. Ghiasi (10910038)

    Published 2021
    “…<p>Robust and reliable QSAR models were developed to predict half-maximal inhibitory concentration (IC<sub>50</sub>) values of hepatitis C virus NS3/4A protease inhibitors from the Monte Carlo technique. 524 HCV NS3/4A protease inhibitors were extracted from the scientific literature to create a reasonably large set. …”
  15. 295
  16. 296
  17. 297

    Data_Sheet_1_Applying the Toyota production system to decrease the time required to transport patients undergoing surgery from the general ward to the operating room and reviewing... by Chien-Chung Lin (244489)

    Published 2022
    “…The time spent on elevator transport decreased by 44.4%. We developed a process for future use based on information-assisted patient and staff identification. …”
  18. 298

    Data_Sheet_2_Applying the Toyota production system to decrease the time required to transport patients undergoing surgery from the general ward to the operating room and reviewing... by Chien-Chung Lin (244489)

    Published 2022
    “…The time spent on elevator transport decreased by 44.4%. We developed a process for future use based on information-assisted patient and staff identification. …”
  19. 299

    Supplementary Material for: Decreasing Trend in Incidence of Late Onset Culture Positive Bloodstream Infections but Not Late Onset Meningitis in Preterm Infants <33 Weeks Gestation... by Zhou Q. (4138852)

    Published 2021
    “…<b><i>Conclusions:</i></b> There was a decreasing trend of late onset CPBSI but not late onset meningitis. …”
  20. 300

    DAF-16/FOXO is Required for Locomotory Healthspan and Lifespan Benefits of Genetic Glycolysis Disruption. by Brian Onken (86790)

    Published 2020
    “…We measured <i>in vivo</i> fluorescence using a spectrofluorimeter on day 5 of life. …”